Inflazome is a startup based in Ireland, most recent round Acquired, 3 tracked investors.
Inflazome is a startup based in Ireland. Inflazome has been acquired. Brouky records 3 investors associated with the company.
Inflazome develops orally available small molecule inhibitors targeting the NLRP3 inflammasome to treat age-related and orphan inflammatory diseases characterized by harmful inflammation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.